Senesco Technologies, Inc.
Get Full AccessDescription
- Senesco is running a Phase 1/2 study in multiple myeloma, diffuse large B-cell lymphoma and mantle cell lymphoma patients with a novel gene regulatory approach. The ability of eukaryotic translation initiation factor 5A (eIF5A) to modulate critical pathways involved in cancer and inflammatory diseases is being investigated.
-
Headquarters:721 Us Highway 202/206 Ste 130, Bridgewater, New Jersey, United States
More -
Phone Number: +1 908-864-4444
-
Website: https://www.senesco.com
-
Employees:3
-
Revenue:$1 - 10M
-
Legal Name:Senesco Technologies, Inc.
-
Senesco Technologies, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Senesco Technologies, Inc.
-
Where are Senesco Technologies, Inc.'s Headquarters?
Senesco Technologies, Inc.'s Headquarters are in 721 Us Highway 202/206 Ste 130,Bridgewater,New Jersey,United States
-
What is Senesco Technologies, Inc.'s phone number?
Senesco Technologies, Inc.'s phone number is +1 908-864-4444
-
What is Senesco Technologies, Inc.'s official website?
Senesco Technologies, Inc.'s official website is https://www.senesco.com
-
What is Senesco Technologies, Inc.'s Revenue?
Senesco Technologies, Inc.'s revenue is $1 - 10M
-
What is Senesco Technologies, Inc.'s NAICS code?
Senesco Technologies, Inc.'s NAICS code is 541713
-
How many employees are working in Senesco Technologies, Inc.
Senesco Technologies, Inc. has 3 employees
-
What is Senesco Technologies, Inc.'s Industry?
Senesco Technologies, Inc. is in the industry of Biotechnology
-
Who is Senesco Technologies, Inc.'s President Of Senesco Technologies, Inc?
Senesco Technologies, Inc.'s President Of Senesco Technologies, Inc is Les Browne

